Interleukin-1 Receptor Blockade Is Associated With Reduced Mortality in Sepsis Patients With Features of Macrophage Activation SyndromeBita Shakoory, Steven M. Opal, Joseph A. Carcillo et al.|Critical Care Medicine|2015Cited by 858
Differential requirement for the activation of the inflammasome for processing and release of IL-1β in monocytes and macrophagesMihai G. Netea, Charles A. Dinarello|Blood|2008Cited by 777
OLT1177, a β-sulfonyl nitrile compound, safe in humans, inhibits the NLRP3 inflammasome and reverses the metabolic cost of inflammationCarlo Marchetti, Charles A. Dinarello, Scott A. Goodrich et al.|Proceedings of the National Academy of Sciences|2018Cited by 556
Consensus conference definitions for sepsis, septic shock, acute lung injury, and acute respiratory distress syndrome: Time for a reevaluationEdward Abraham, John E. Repine, Michael A. Matthay et al.|Critical Care Medicine|2000Cited by 372
IL-1 family nomenclatureCharles A. Dinarello, Chiristopher Gabel, William P. Arend et al.|Nature Immunology|2010Cited by 341